Question follow-through · 103088

Rare Diseases: Gene Therapies

To ask the Secretary of State for Health and Social Care, what steps he is taking to support the development of gene therapy treatments for rare genetic diseases such as tyrosinemia and Gaucher disease.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
5 Jan 2026
Target answer date
12 Jan 2026
Answer
12 Jan 2026 · 7 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 5 Jan 2026

    Question tabled

    To ask the Secretary of State for Health and Social Care, what steps he is taking to support the development of gene therapy treatments for rare genetic diseases such as tyrosinemia and Gaucher disease.

  2. 12 Jan 2026

    Target answer date

    Date supplied by the official written-questions record.

  3. 12 Jan 2026

    Answer published

    The Government is committed to improving the lives of those living with rare diseases, such as tyrosinemia and Gaucher disease. Through the UK Rare Diseases Framework, the Government supports access to specialist care, treatment, and drugs as a priority. ...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Maternity Services

9 Jan 2026 · To ask the Secretary of State for Health and Social Care, what support for training and resources his Department is providing to integrated care boards to help implement the NHS England Maternal Care Bundle, published on 6 January 2026.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Givinostat

13 Jan 2026 · To ask the Secretary of State for Health and Social Care, what discussions has he had to help conclude the dialogue between NHS England and the manufacturer of givinostat as part of the NICE appraisal.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Maternity Services: Standards

15 Jan 2026 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of effectiveness of Maternity and Neonatal Voices Partnerships (MNVP), including Oxfordshire MNVP in representing the experience of mothers and families.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Disclosure of Information

15 Jan 2026 · To ask the Secretary of State for Health and Social Care, if he will bring forward legislative proposals to introduce protections for (a) whistleblowing patients and (b) patient safety advocates.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Surgery: Waiting Lists

15 Jan 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of activity management plans on patient waiting times for elective surgery.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Standards

15 Jan 2026 · To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of patients whose treatment has been delayed as a result of restrictions placed on private providers delivering NHS services.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Waiting Lists

15 Jan 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the 18-week waiting time target can be met.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Negligence

4 Feb 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the length of time medical malpractice legal proceedings take to complete on (a) families and (b) staff.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Dementia: Research

4 Feb 2026 · To ask the Secretary of State for Health and Social Care, how much funding was allocated to dementia research by (a) the National Institute for Health and Care Research and (b) UK Research and Innovation in each of the last five years.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Hormone Replacement Therapy

10 Feb 2026 · To ask the Secretary of State for Health and Social Care, pursuant to to the answers of 5 and 17 October 2025 to Questions 77387 and 86538, what progress he has made on ensuring a reliable supply of testosterone and oestrogen HRT implants.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Givinostat

10 Feb 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the answer of 19th January to question 105612, to ask what role the Department for Health and Social Care will have in drug price negotiations following the abolishment of NHS England.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Alzheimer's Disease: Carers

11 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether his Department plans to ensure that the (a) psychological, (b) social and (b) financial impacts of caring for someone with Alzheimer’s disease are accounted for as part of National Institut